Canadian Cancer Trials Group

We track 3 ClinicalTrials.gov studies led by Canadian Cancer Trials Group. The portfolio skews toward Phase 2 (2 trials).

3 clinical trials sponsored by Canadian Cancer Trials Group.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
67%
Phase 3 1
33%

Trial Status Breakdown

Trials by Canadian Cancer Trials Group

Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma: The BATTMAN Trial

NCT07152821 · RECRUITING · Phase 3

A Liquid-biopsy Informed Platform Trial to Evaluate Treatment in CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

NCT05601440 · RECRUITING · Phase 2

A Phase Ib and Open Label Phase II Study of CFI-402257 in Combination With Weekly Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer

NCT03568422 · ACTIVE NOT RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Canadian Cancer Trials Group sponsor?

Canadian Cancer Trials Group currently sponsors 3 clinical trials tracked on ReadTheTrial. These span Phase 2, Phase 3.

What conditions does Canadian Cancer Trials Group research?

Canadian Cancer Trials Group conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Canadian Cancer Trials Group recruiting for clinical trials?

Yes, Canadian Cancer Trials Group currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More